Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

European Wax Center (EWCZ) Other financing activities (2021 - 2025)

Historic Other financing activities for European Wax Center (EWCZ) over the last 5 years, with Q4 2025 value amounting to $8000.0.

  • European Wax Center's Other financing activities fell 9487.18% to $8000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$380000.0, marking a year-over-year decrease of 16921.68%. This contributed to the annual value of $12.4 million for FY2022, which is 85973.72% up from last year.
  • European Wax Center's Other financing activities amounted to $8000.0 in Q4 2025, which was down 9487.18% from $2000.0 recorded in Q3 2025.
  • European Wax Center's 5-year Other financing activities high stood at $11.5 million for Q2 2022, and its period low was -$549000.0 during Q1 2025.
  • Over the past 5 years, European Wax Center's median Other financing activities value was $156000.0 (recorded in 2024), while the average stood at $960200.0.
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 4340000.0% in 2022, then crashed by 9982.68% in 2023.
  • European Wax Center's Other financing activities (Quarter) stood at $566000.0 in 2021, then soared by 1940.46% to $11.5 million in 2022, then plummeted by 96.75% to $375000.0 in 2023, then plummeted by 58.4% to $156000.0 in 2024, then plummeted by 94.87% to $8000.0 in 2025.
  • Its Other financing activities was $8000.0 in Q4 2025, compared to $2000.0 in Q3 2025 and $159000.0 in Q2 2025.